WOAG
WITHDRAWAL OF ATTORNEY GRANTED
08/08/2024
Back to search
Official data from USPTO
BLUE NOTE THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BLUE NOTE THERAPEUTICS
ST13
US500000088935977Class
9, 42
Filing
88935977
Registration
6821675
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
08/08/2024
Classification
Registered
Trademark type
Word
Nice classes
9, 42
Filing date
05/27/2020
Registration date
08/16/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/16/2022
Last transaction
08/08/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-03-00
First use in commerce
2021-03-00
Drawing code
4
Owner type
03
Owner location
San Francisco, CA
Examiner
FRIZALONE, SARAH O
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Blue Note Therapeutics, Inc.
Representatives
Blue Note Therapeutics, Inc.
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software for diagnosing and treating psychological and related physiological comorbidities of severe acute and chronic diseases
Class 42
Providing temporary use of non-downloadable computer software for diagnosing and treating psychological and related physiological comorbidities of severe acute and chronic diseases
Publications
History of USPTO decisions and trademark events.
34 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
08/08/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/16/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/16/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/14/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/13/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/31/2022
GNRT
NON-FINAL ACTION E-MAILED
01/31/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/31/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/15/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/14/2021
EX1G
SOU EXTENSION 1 GRANTED
12/14/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/14/2021
IUAF
USE AMENDMENT FILED
12/06/2021
EXT1
SOU EXTENSION 1 FILED
12/06/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/06/2021
EISU
TEAS STATEMENT OF USE RECEIVED
12/06/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/15/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/20/2021
PUBO
PUBLISHED FOR OPPOSITION
04/20/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/31/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/26/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/31/2020
GNRT
NON-FINAL ACTION E-MAILED
08/31/2020
CNRT
NON-FINAL ACTION WRITTEN
08/31/2020
DOCK
ASSIGNED TO EXAMINER
08/27/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/16/2020
NWAP
NEW APPLICATION ENTERED
05/30/2020
Continuous trademark protection
Get notified about every new filing that threatens BLUE NOTE THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.